TABLE 4.
4 DAI | 5 DAI | 6 DAI | 7 DAI | |
ctr + | 344.37 ± 17.28A | 951.94 ± 46.8A | 1479.47 ± 73.6A | 2207.29 ± 109.5A |
PE 500 ng/mL | 0F | 0F | 0G | 0E |
PE 100 ng/mL | 0F | 0F | 93.01 ± 4.65F | 157.01 ± 7.26D |
PE 50 ng/mL | 0F | 77.33 ± 3.48E | 107.54 ± 5.34F | 170.60 ± 8.45D |
LE 100 μg/mL | 84.50 ± 4.22E | 180.67 ± 9.15D | 364.23 ± 18.84C | 725.45 ± 35.72B |
LE 10 μg/mL | 113.40 ± 5.62D | 209.41 ± 11.01E | 244.15 ± 12.94D | |
LE 1 μg/mL | 0F | 233.45 ± 11.75C | 274.90 ± 13.81D | 535.01 ± 26.88C |
PE 50 ng/mL + LE 1 μg/mL | 172.28 ± 8.59C | 216.16 ± 10.79CD | 200.68 ± 10.82E | 619.10 ± 29.61C |
PE 50 ng/mL + LE 10 μg/mL | 311.88 ± 14.7B | 356.79 ± 18.84B | 389.97 ± 19.59C | 742.48 ± 36.98B |
PE 100 ng/mL + LE 10 μg/mL | 180.89 ± 9.12C | 192.07 ± 9.53D | 465.77 ± 23.56B | 726.72 ± 34.87B |
Values are reported as means ± SD. AFB1 production was monitored: 4, 5, 6, and 7 DAI. Negative control (ctr−) and positive control (ctr+) corresponded, respectively, to non-inoculated growth medium amended with extracts, and infected growth medium without extracts. Small capital letter in the charts represent the significantly different groups (p < 0.05; Tukey test).